NOUVEAU COMPOSÉ CARBAMOYLOXY ARYLE ALCANE ARYLPIPÉRAZINE, COMPOSITIONS PHARMACEUTIQUES COMPRENANT CE COMPOSÉ ET MÉTHODE DE TRAITEMENT DE LA DOULEUR, DE L'ANXIÉTÉ ET DE LA DÉPRESSION PAR ADMINISTRATION DE CE COMPOSÉ
There is provided a novel carbamoyloxy arylalkanoyl arylpiperazine derivative compound having abundant racemic or enantiomeric characteristics, represented by the Formula 1, and pharmaceutically available salts or hydrates thereof. Also, there are provided a pharmaceutical composition for treating pain, anxiety or depression including an effective amount of the compound, and a method for treating pain, anxiety or depression in mammals by administering an effective amount of the compound to the mammals in need of treatment thereof.